If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 16.50
Ask: 17.50
Change: -0.50 (-2.86%)
Spread: 1.00 (6.061%)
Open: 17.50
High: 17.50
Low: 17.00
Prev. Close: 17.50
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: STV raises holding in Two Cities Television

Wed, 31st Jan 2024 18:28

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Ethernity Networks Ltd - Israel-based supplier of data processing semiconductor technology for networking appliances - Announces the formal conclusion of the temporary suspension of proceedings process. Anticipates that the court will submit its formal approval of the settlement proposal during the first two weeks of February. Notwithstanding this, it is not considered necessary to seek a further extension to the TSP. Chief Executive David Levi comments: "We are delighted for the company to be able to conclude the TSP process. We exit the TSP on a far stronger financial footing than when we entered, thanks to the encouraging customer contracts and the fundraise we undertook in December.

----------

GreenRoc Mining PLC - UK and Greenland-focused mineral explorer - Announces the successful results of electrochemical battery test work using graphite from its Amitsoq graphite project in southern Greenland, and an update on its processing plant feasibility study. Chief Executive Stefan Bernstein says: "The outcome of this battery test programme is hugely pleasing. This is the first time that graphite material from our Amitsoq project has been tested for its performance within an assembled lithium ion battery cell. These results demonstrate that uncoated purified spherical graphite from Amitsoq performs very well as the active anode material in a battery cell, which is excellent news." Company says that the first and second work phases of the feasibility study are now complete. The next stages of the feasibility study include the design of both a pilot and full-scale processing plant, estimation of production rates, energy requirements and consumables, a full discounted cash flow model for the full-scale processing plant and integrating a risk model.

----------

Somero Enterprises Inc - Fort Myers, Florida-based laser-guided concrete levelling machinery company - Says following good trading and an excellent operational performance in fulfilling customer orders globally during the second half, it expects to report 2023 revenue of USD120.7 million, in line with previous guidance and market expectations. The 2023 revenue expectation reflects the positive impact of the S-22EZ relaunch at full production on trading and a resilient US non-residential construction market. A strong finish to the year was achieved despite ongoing headwinds in the US from concrete supply chain shortages, elevated interest rates and tightened bank lending. In 2024, expects the US market to remain strong, supported by customers reporting high levels of activity and healthy backlogs, continued growth in Europe and Australia, and multiple new product launches. Expects 2024 will be another highly profitable year with healthy cash generation, revenue comparable to 2023, and earnings before interest, tax, depreciation and amortisation that reflects modest incremental investment including the new Belgium service and training centre and the annualized impact of strategic resources added in 2023.

----------

Hummingbird Resources PLC - West Africa-focused and Birmingham, England-based gold producer, developer and explorer - Reports adjusted earnings before interest, tax, depreciation and amortisation in the fourth quarter ending December of USD0.2 million, resulting adjusted Ebitda for 2023 as a whole of USD34.5 million. Yanfolila produced 14,419 ounces of gold in the quarter, with a total of 83,965 oz in 2023, meeting production guidance of 80,000 to 90,000 oz. All in sustaining cost on gold produced at Yanfolila totalled USD1,701 per oz in the quarter, and USD1,361 per oz (in the year compared to USD1,782 per oz in 2022. This met the 2023 AISC guidance of under USD1,500/oz. Group production guidance for 2024 is 165,000 to 200,000 oz at an AISC below USD1,500, which is weighted towards the second half. Expects to spend USD5 million on exploration across both Yanfolila and Kouroussa.

----------

STV Group PLC - Glasgow-based television broadcaster and content producer - Increases its 25% equity stake in the high-end drama production company, Two Cities Television, to a majority holding of 51%. Explains the drama producer has secured revenue of GBP55 million over next 3 years across multiple series. Investment will help underpin Two Cities' growth and strengthen STV Studios' position as leading Nations & Regions producer. STV acquired a minority stake in Two Cities in January 2020, with an option to increase its initial stake to a majority position upon Two Cities becoming profitable.

----------

Botswana Diamonds PLC - Botswana and South Africa-focused diamond explorer - Announces that a consortium including BOD, which is acting as operator with a 30% stake, collectively known as Diamonds of Eswatini Pty Ltd, has been awarded a prospecting license over the diamondiferous Dokowayo kimberlites in Eswatini. Nil consideration was payable by BOD for its 30% interest. The License of just under 4,000 hectares is for an initial period of one year and renewable for a further year. The plan is to undertake an immediate, updated full desktop review and analysis of secondary sources. Following this, bulk sampling of the dumps and kimberlite stockpile is envisaged as the next step forward.

----------

Ariana Resources PLC - mineral exploration and development company with gold mining interests in Turkey, Cyprus and Kosovo - Updates on the 100% owned Asgard Metals Fund, highlighting some of its associated investments. Reports due diligence drilling programme on the Dokwe Gold project in Zimbabwe is ongoing, with the company increasing the current investment in Rockover Holdings to 2.1% by investing a further USD150,000. Highlights increased investment in Panther Metals to circa 5.5%, following an agreement to extend the consulting input of Asgard by a further year to the end of 2024. Notes Pallas Resources agrees an option and joint venture agreement with First Quantum Minerals, whilst securing BHP funding through their Xplor programme.

----------

Destiny Pharma PLC - Brighton, England-based biotechnology company - Announces positive data from a pivotal preclinical safety study of XF-73 Dermal, used for the treatment of antibiotic resistant skin infections associated with open wounds and broken skin. The product was well tolerated with no significant impact on any clinical or safety parameters and had no apparent negative impact on wound healing. Intends initially to progress XF-73 Dermal towards clinical evaluation for the treatment of Diabetic Foot Infections and serious burn wound infections. Further, changes its contract development manufacturing organisation for NTCD-M3 in order to strengthen manufacturing for clinical trial material and improve future commercial supply. These changes mean that the company now expect drug product for the next stage of clinical development to be available in the second half of 2024.

----------

Mobile Streams PLC - London-based mobile content provider - Completes the acquisition of all associated intellectual property for the print and digital operations of Estadio, and Capital Media Group has also transferred and recruited employees to work on the publication. Believes this provides a solid foundation for the relaunch and extension of the brand. Preparations for the launch of the Mexican betting business (in which MOS has a 25% direct shareholding) are well underway and the business is on track to launch early in the second quarter.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
29 Jun 2023 18:55

TRADING UPDATES: Ecofin US Renewables expects to pay reduced dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

Read more
26 May 2023 10:51

Polarean shares down despite narrowed annual loss and optimism

(Alliance News) - Polarean Imaging PLC shares were down on Friday despite slimming its annual loss, as the company said it now will focus on gaining commercial traction and exploring further financing for its newly US Food & Drug Administration-approved Xenoview device.

Read more
25 May 2023 10:42

IN BRIEF: Destiny Pharma picks interim CEO as Clark makes quick exit

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Chief Executive Officer Neil Clark steps down immediately "to pursue new challenges". Clark will "support [Destiny] for a limited period to ensure an orderly handover." Non-Executive Director Debra Barker will serve as interim CEO until Destiny appoints a permanent replacement. Barker has held "key roles" at Novartis AG and Polyphor AG, now named Spexis AG. She also has previously worked at Roche Holding AG, Polyneuron Pharmaceuticals AG and GSK PLC.

Read more
18 May 2023 15:03

UK shareholder meetings calendar - next 7 days

Friday 19 May 
Bank of Georgia Group PLCAGM
Permanent TSB Group Holdings PLCAGM
Sancus Lending Group LtdAGM
Monday 22 May 
Blackrock Latin American Investment Trust PLCAGM
Crossword Cybersecurity PLCAGM
Judges Scientific PLCAGM
Stelrad Group PLCAGM
Venture Life Group PLCAGM
Tuesday 23 May 
888 Holdings PLCAGM
Access Intelligence PLCAGM
Arix Bioscience PLCAGM
Bank of Ireland Group PLCAGM
Big Technologies PLCAGM
Bigblu Broadband PLCAGM
Centamin PLCAGM
CT Private Equity Trust PLCAGM
Empresaria Group PLCAGM
Epwin Group PLCAGM
Forterra PLCAGM
Fresnillo PLCAGM
Fulcrum Utility Services LtdGM re issue of conversion shares
Gresham Technologies PLCAGM
Harworth Group PLCAGM
Hilton Food Group PLCAGM
hVIVO PLCAGM
HydrogenOne Capital Growth PLCAGM
IQ-AI LtdAGM
JTC PLCAGM
K3 Business Technology Group PLCAGM
Pebble Group PLCAGM
Portmeirion Group PLCAGM
PPHE Hotel Group LtdAGM
Restaurant Group PLCAGM
Shell PLCAGM
Sherborne Investors (Guernsey) C LtdAGM
TMT Investments PLCAGM
Triple Point Income VCT PLCAGM
Triple Point Social Housing REIT PLCAGM
Trustpilot Group PLCAGM
Twentyfour Income Fund LtdAGM
Wickes Group PLCAGM
Xeros Technology Group PLCAGM
Wednesday 24 May 
4imprint Group PLCAGM
Adriatic Metals PLCAGM
Arbuthnot Banking Group PLCAGM
Artisanal Spirits Co PLCAGM
Bango PLCAGM
Coca-Cola Europacific Partners PLCAGM
Deliveroo PLCAGM
Deltic Energy PLCAGM
Distribution Finance Capital Holdings PLCAGM
Dunedin Enterprise Investment Trust PLCAGM
ECSC Group PLCCourt and General Meetings re Daisy Corporate Services Trading Ltd takeover
Empiric Student Property PLCAGM
Fidelity Japan Trust PLCAGM
HICL Infrastructure PLCAGM
Horizonte Minerals PLCAGM
Intertek Group PLCAGM
Ithaca Energy PLCAGM
Kelso Group Holdings PLCAGM
Lookers PLCAGM
M&G PLCAGM
Mercantile Investment Trust PLCAGM
Microlise Group PLCAGM
Mortgage Advice Bureau Holdings PLCAGM
National World PLCAGM
Ondine Biomedical IncAGM
Petershill Partners PLCAGM
Playtech PLCAGM
Quarto Group IncAGM
Real Estate Investors PLCAGM
Tullow Oil PLCAGM
US Solar Fund PLCAGM
Zotefoams PLCAGM
Thursday 25 May 
Alliance Pharma PLCAGM
Biome Technologies PLCAGM
Capital & Regional PLCAGM
Destiny Pharma PLCAGM
Ferrexpo PLCAGM
Fevertree Drinks PLCAGM
Headlam Group PLCAGM
Henry Boot PLCAGM
Hill & Smith PLCAGM
LBG Media PLCAGM
Life Science REIT PLCAGM
LSL Property Services PLCAGM
NAHL Group PLCAGM
Petrofac LtdAGM
Pharos Energy PLCAGM
Prudential PLCAGM
Regional REIT LtdAGM
Resolute Mining LtdAGM
RM PLCAGM
S&U PLCAGM
Sabre Insurance Group PLCAGM
Schroder Asian Total Return Investment Co PLCAGM
TBC Bank Group PLCAGM
Vanquis Banking Group PLCAGM
Zinc Media Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
2 May 2023 19:22

TRADING UPDATES: Macfarlane buys A&G Holdings for GBP3.6 million

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Apr 2023 14:16

Destiny Pharma loss widens as it extends cash runway

(Sharecast News) - Biotechnology company Destiny Pharma reported a loss before tax of £7.7m in its 2022 results on Thursday, widening from £6.3m in the prior year.

Read more
13 Apr 2023 13:59

IN BRIEF: Destiny Pharma annual loss widens as expenses grow

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology - Pretax loss widens to GBP7.7 million for 2022 from GBP6.3 million in 2021. Administrative expenses increase to GBP7.4 million from GBP6.0 million a year earlier. Research & development expenditure amounts to GBP4.9 million, up from GBP3.7 million in 2021. Looking ahead, Destiny Pharma says it will focus on completing the manufacturing scale-up to deliver clinical trial material for the NTCD-M3 clinical programme being run by our partner Sebela. Chief Executive Officer Neil Clark says: "Destiny Pharma has made good progress in 2022 and in the first quarter of 2023."

Read more
6 Apr 2023 15:42

UK earnings, trading statements calendar - next 7 days

Friday 7 April 
no events scheduled 
Monday 10 April 
no events scheduled 
Tuesday 11 April 
Devolver Digital IncFull Year Results
JTC PLCFull Year Results
Wednesday 12 April 
Argentex Group PLCQ3 Results
DP Eurasia NVFull Year Results
Everyman Media Group PLCFull Year Results
LBG Media PLCFull Year Results
Tharisa PLCTrading Statement
Thursday 13 April 
Brooks Macdonald Group PLCTrading Statement
Churchill China PLCFull Year Results
Destiny Pharma PLCFull Year Results
discoverIE Group PLCTrading Statement
Foresight Group Holdings LtdTrading Statement
Imperial Brands PLCTrading Statement
LSL Property Services PLCFull Year Results
Norcros PLCTrading Statement
PZ Cussons PLCTrading Statement
Tesco PLCFull Year Results
XP Power LtdTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
4 Apr 2023 11:33

Destiny Pharma upbeat on infection prevention study

(Sharecast News) - Destiny Pharma said in an update on Tuesday that its novel medicine for preventing life-threatening infections, 'NTCD-M3', had been shown to colonise the gut successfully in a C difficile infection (CDI) model study after the administration of fidaxomicin.

Read more
24 Mar 2023 15:34

Destiny publishes 'important' research on its preoperative treatment candidate

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the publication of landmark clinical data for 'XF-73' on Friday, in the US-based peer-reviewed journal Infection Control & Hospital Epidemiology.

Read more
16 Mar 2023 06:54

IN BRIEF: Destiny Pharma raises GBP7.3 million total in equity raise

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology - Gets 33% take-up of open offer of shares, raising GBP340,000. Destiny raises GBP7.3 million gross in total from the open offer, plus a share placing and subscription, all at 35 pence per share. Net proceeds are GBP6.7 million, which will be used to support a collaboration agreement in the US with Sebela Pharmaceuticals for NTCD-M3, Destiny's lead asset for the prevention of clostridioides difficile infection recurrence.

Read more
24 Feb 2023 14:28

Destiny shares fall on fundraise discount despite USD570 million deal

(Alliance News) - Destiny Pharma PLC on Friday said that it has signed a collaboration agreement with Sebela Pharmaceuticals for NTCD-M3, its lead asset for the prevention of clostridioides difficile infection recurrence.

Read more
25 Jan 2023 20:03

TRADING UPDATES: Appreciate gets court date; Corcel completes sale

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
22 Dec 2022 14:06

Destiny Pharma jumps on 2022 progress

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma updated the market on its progress in 2022 on Thursday, including working to finalise a partnering agreement for 'NTCD-M3', which it described as its "most advanced" clinical programme, targeted at infection prevention.

Read more
22 Dec 2022 12:10

LONDON MARKET MIDDAY: UK stocks rise as Paris and Frankfurt head lower

(Alliance News) - Stock prices in London were higher at midday on Thursday, ahead of some key US economic data, while equities elsewhere were less buoyant.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.